This inventor holds 1 USPTO granted patent. Top assignees: Biomeasure Incorporated, Societe De Conseils De Recherches Et D'applications Scientifiques. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1998
Title: Evelyn Deschamps De Paillette: Innovator in Hematology
Introduction
Evelyn Deschamps De Paillette is a notable inventor based in Paris, France. She has made significant contributions to the field of hematology, particularly in the regeneration of hemopoietic cells. Her innovative approach addresses the challenges faced by patients undergoing chemotherapy or radiotherapy.
Latest Patents
Evelyn holds a patent for a method titled "Protection of hemopoietic cells." This method promotes the regeneration of hemopoietic cells in subjects undergoing chemotherapy or radiotherapy. The process involves administering a first amount of AcSDKP or an agonist to reduce the proliferation of hemopoietic cells during treatment. Additionally, it includes administering an angiotensin-converting enzyme (ACE) inhibitor to minimize the degradation of AcSDKP. Finally, after treatment, a hemopoiesis growth factor is administered to stimulate the proliferation of hemopoietic cells. This innovative method showcases her commitment to improving patient outcomes.
Career Highlights
Evelyn has worked with several companies throughout her career, including Biomeasure Incorporated and Société de Conseils de Recherches et d'Applications Scientifiques. Her experience in these organizations has contributed to her expertise in the field of medical research and innovation.
Collaborations
Evelyn has collaborated with various professionals in her field, including her coworker Arthur E. Bogden. These collaborations have further enhanced her research and development efforts.
Conclusion
Evelyn Deschamps De Paillette is a pioneering inventor whose work in the protection and regeneration of hemopoietic cells has the potential to significantly impact cancer treatment. Her innovative methods and dedication to research exemplify the spirit of invention in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile